Halda Therapeutics, LLC — Form D
Halda Therapeutics, LLC of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-24. The offering totals $36.0M, of which $24.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-05-24
- Form: D
- Accession: 0001769401-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $36.0M
- Amount sold: $24.2M
- Remaining: $11.8M
- Investors: 9
- Date of first sale: 2024-05-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-514297
Issuer
- Name: Halda Therapeutics, LLC
- CIK: 0001769401
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 115 MUNSON STREET, NEW HAVEN, CT, 06511
- Phone: 8606558653
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Scott Phillips | Executive Officer | Houston, TX |
| Rebecca Luse | Director | Boston, MA |
| Tim Shannon | Director | Westport, CT |
| Tim Shannon | Executive Officer | Westport, CT |
| Joe Cabral | Director | Charlestown, MA |
| Arjun Goyal | Director | Watertown, MA |
| Liam Ratcliffe | Director | New York, NY |
| Nandita Shangari | Director | Boston, MA |
| Rebecca Frey | Director | Madison, CT |
| Leyi Wang | Director | Cambridge, MA |
| Wei Zhao | Director | San Diego, CA |
Other filings by this issuer (3)
More